The MiTy trial reported a comparable incidence of neonatal hypoglycemia between insulin plus metformin versus insulin plus placebo in patients with T2DM (RR 0.82, 95% CI 0.52 to 1.30) [31]. Here, INS is linked to type 2 diabetes mellitus.